Skip to Main Content

Paper Details

Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease.
Clin Cancer Res
5
2021
Author NameAffiliation
Felix Y FengHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
Alexander W WyattThe University of British Columbia
Gerhardt AttardUniversity College London Cancer Institute
Eric J SmallHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
  • 1 - 4

Datasets

Release 1.2